tryptophanase inhibitor (Daiichi Sankyo)

N/A

Report date: 2025/03/20 09:45:40
NME

Base Information

Drug Nametryptophanase inhibitor (Daiichi Sankyo)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTryptophan 2,3-dioxygenase inhibitors
TargetsTryptophan 2,3-dioxygenase
Therapy Area/IndicationsUremiaKidney Failure, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsUremiaKidney Failure, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A